Is SPEYF or JNJ a better dividend investment in 2026?

SPEYF currently yields 1042.21% with a 5% 5-year dividend growth rate. JNJ yields 3.36% with 5.8% growth. The better choice depends on your goal: SPEYF offers higher current income.

What is the dividend yield difference between SPEYF and JNJ?

SPEYF has a forward dividend yield of 1042.21% ($2.00/share annually). JNJ yields 3.36% ($4.96/share annually). The yield gap is 1038.85 percentage points.

Home › Compare › SPEYF vs JNJ

SPEYF vs JNJ: Dividend Comparison 2026

SPEYF yields 1042.21% · JNJ yields 3.36%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 SPEYF wins by $27046683.04M in total portfolio value

INVESTMENT

TIME HORIZON10 years

SPEYF

● Live price

1042.21%

Share price

$0.19

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$27046683.06M

Annual income

$22,752,239,440,492.35

Full SPEYF calculator →

JNJ

Johnson & Johnson

● Live price

3.36%

Share price

$147.50

Annual div

$4.96

5Y div CAGR

5.8%

Payout ratio

55%

After 10 yrs · $10,000 · DRIP

Portfolio value

$20.0K

Annual income

$827.78

Full JNJ calculator →

Portfolio growth — SPEYF vs JNJ

📍 SPEYF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	SPEYF	JNJ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, SPEYF + JNJ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

SPEYF pays

JNJ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SPEYF

Annual income on $10K today (after 15% tax)

$88,587.81/yr

After 10yr DRIP, annual income (after tax)

$19,339,403,524,418.50/yr

JNJ

Annual income on $10K today (after 15% tax)

$285.83/yr

After 10yr DRIP, annual income (after tax)

$703.61/yr

At 15% tax rate, SPEYF beats the other by $19,339,403,523,714.89/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SPEYF + JNJ for your $10,000?

SPEYF: 50%JNJ: 50%

100% JNJ50/50100% SPEYF

Portfolio after 10yr

$13523341.54M

Annual income

$11,376,119,720,660.07/yr

Blended yield

84.12%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

SPEYF

No analyst data

Altman Z

-4.5

Piotroski

1/9

JNJ

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$228.73

+55.1% upside vs current

Range: $190.00 — $265.00

Altman Z

5.2

Piotroski

4/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SPEYF buys

JNJ buys

No recent congressional trades found for SPEYF or JNJ in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricSPEYFJNJ

Forward yield	1042.21% ✓	3.36%
Annual dividend / share	$2.00	$4.96 ✓
Payout ratio	50% ✓	55%
1-year div growth	0%	4.2% ✓
5-year div CAGR	0%	5.8% ✓
Portfolio after 10y	$27046683.06M ✓	$20.0K
Annual income after 10y	$22,752,239,440,492.35 ✓	$827.78
Total dividends collected	$26720423.44M ✓	$5.6K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: SPEYF vs JNJ ($10,000, DRIP)

Year	SPEYF Portfolio	SPEYF Income/yr	JNJ Portfolio	JNJ Income/yr	Gap
1← crossover	$114,921	$104,220.95	$10,676	$355.77	+$104.2K → SPEYF
2	$1,242,327	$1,119,361.70	$11,407	$389.39	+$1.23M → SPEYF
3	$12,638,270	$11,308,979.87	$12,198	$426.53	+$12.63M → SPEYF
4	$121,043,458	$107,520,509.44	$13,056	$467.62	+$121.03M → SPEYF
5	$1,091,928,952	$962,412,451.55	$13,987	$513.12	+$1091.91M → SPEYF
6	$9,282,280,098	$8,113,916,119.31	$14,998	$563.56	+$9282.27M → SPEYF
7	$74,394,521,856	$64,462,482,151.61	$16,098	$619.52	+$74394.51M → SPEYF
8	$562,449,134,568	$482,846,996,181.38	$17,295	$681.69	+$562449.12M → SPEYF
9	$4,013,498,710,236	$3,411,678,136,248.56	$18,599	$750.82	+$4013498.69M → SPEYF
10	$27,046,683,060,445	$22,752,239,440,492.35	$20,022	$827.78	+$27046683.04M → SPEYF

SPEYF vs JNJ: Complete Analysis 2026

SPEYF — Stock

Spey Resources Corp. engages in the acquisition, exploration, and development of mineral properties in Canada. The company explores for silver and lithium deposits. It holds an option to acquire a 100% undivided interest in the Silver Basin project located in the Revelstoke Mining Division of British Columbia; and the Kaslo Silver property situated in southern British Columbia. The company also owns an option to acquire a 100% interest in the Candella II project located in Salar de Incahuasi, Argentina; and Pocitos I and II situated in Salta, Argentina. Spey Resources Corp. was incorporated in 2017 and is based in Vancouver, Canada.

Full SPEYF Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →

📬

Get this SPEYF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SPEYF vs SCHD SPEYF vs JEPI SPEYF vs O SPEYF vs KO SPEYF vs MAIN SPEYF vs ABBV SPEYF vs MRK SPEYF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.